This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

MorphoSys Future Growth

Future criteria checks 5/6

MorphoSys is forecast to grow earnings and revenue by 82.3% and 26.2% per annum respectively. EPS is expected to grow by 97.8% per annum. Return on equity is forecast to be 7.7% in 3 years.

Key information

82.3%

Earnings growth rate

97.8%

EPS growth rate

Biotechs earnings growth0%
Revenue growth rate26.2%
Future return on equity7.7%
Analyst coverage

Low

Last updated06 Aug 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

BUL:MOR - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026470-12-120-503
12/31/2025356-107-236-2015
12/31/2024258-56-296-2531
3/31/2024241-469-286-284N/A
12/31/2023238-190-299-296N/A
9/30/2023223104-363-355N/A
6/30/2023255100-349-338N/A
3/31/2023261-61-321-306N/A
12/31/2022278-151-382-367N/A
9/30/2022250-861-436-417N/A
6/30/2022195-851-606-588N/A
3/31/2022174-596-610-583N/A
12/31/2021180-514-508-481N/A
9/30/2021163-150-423-393N/A
6/30/2021143-103-295-246N/A
3/31/2021124-177-255-217N/A
12/31/202032898-1435N/A
9/30/2020303642663N/A
6/30/202029310598113N/A
3/31/2020309153137152N/A
12/31/201972-103-85-81N/A
9/30/201971-96-68-64N/A
6/30/2019114-42-42-39N/A
3/31/201987-59-33-31N/A
12/31/201876-56-35-33N/A
9/30/201894-27-16-14N/A
6/30/201854-82-61-48N/A
3/31/201858-74-68-55N/A
12/31/201767-70N/A-38N/A
9/30/201752-84N/A-52N/A
6/30/201749-73N/A-59N/A
3/31/201749-68N/A-47N/A
12/31/201650-60N/A-47N/A
9/30/201649-45N/A-48N/A
6/30/201648-40N/A-41N/A
3/31/201648-33N/A-35N/A
12/31/201510615N/A-24N/A
9/30/201511127N/A-15N/A
6/30/201511633N/A-3N/A
3/31/201511937N/A-4N/A
12/31/201464-3N/A-14N/A
9/30/201461-6N/A-15N/A
6/30/201460-5N/A79N/A
3/31/2014777N/A76N/A
12/31/2013787N/A89N/A
9/30/20138014N/A100N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: MOR is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (3%).

Earnings vs Market: MOR is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: MOR is expected to become profitable in the next 3 years.

Revenue vs Market: MOR's revenue (26.2% per year) is forecast to grow faster than the BG market (24.4% per year).

High Growth Revenue: MOR's revenue (26.2% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: MOR's Return on Equity is forecast to be low in 3 years time (7.7%).


Discover growth companies